Skip to main content
S&P 5007,637.76+1.14%DOW51,778.04+0.61%NASDAQ26,418.30+1.69%BTC$77,954.00+2.09%ETH$2,503.69+2.71%GOLD$4,412.30+0.29%OIL$96.34-0.92%
Smart Investors Daily
FT

NASDAQ · FTRP

Field Trip Health Ltd.

Healthcare · Medical - Care Facilities

$0.84

Up+$0.01 (+1.07%)

Updated Sep 18, 2026, 11:22 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
9.81M
P/E ratio
-0.14
Dividend yield
0.00%
52-week range
— – —
Volume
163.87K
Avg. volume
61.09K

Price performance

FTRP price history

1M range · 0 trading sessions · Daily adjusted prices

FTRP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest FTRP news

The latest Smart Investors Daily articles mentioning FTRP.

Stock researchCompany · Overview

FTRP research

Overview

Company profile and research snapshot.

Company profile

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
FTRP recent ratings
DateFirmRatingTarget
Nov 22, 2021HC Wainwright & Co.Buy—
Sep 1, 2021HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Aug 16, 2022

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or “Reunion”), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares (the "Shares") will commence trading on the Toronto Stock Exchange (“TSX”) under the ticker symbol “REUN” at the opening of the market on August 17, 2022.

GlobeNewswire Inc. · Aug 15, 2022

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022

TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly “Field Trip Health Ltd.”, or the “Company”) (TSX: FTRP, Nasdaq: FTRP), a leader in novel psychedelic drug development, reported fiscal first quarter 2023 results for the three-month period ended June 30, 2022. All results are reported under International Financial Reporting Standards ("IFRS") and in Canadian dollars, unless otherwise specified.

GlobeNewswire Inc. · Aug 11, 2022

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing

- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN"- Field Trip Health & Wellness Ltd. to be listed on the TSX Venture Exchange under ticker symbol “FTHW” - First day of trading for both Reunion and Field Trip Health & Wellness expected to occur on or about August 17, 2022

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By